A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis

NCT01119859 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

326

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Tocilizumab
DRUG: Adalimumab
DRUG: Placebo to tocilizumab
DRUG: Placebo to adalimumab

Sponsor

Hoffmann-La Roche